Kalorama: Transdermal Patch Market Grows to $7 Billion

NEW YORK, Jan. 8, 2016 /PRNewswire/ -- The global market for transdermal patch drug delivery reached $7 billion in 2015, an increase of $238 million over 2014, according to Kalorama Information. In the transdermal route of delivery, drugs are administered by applying a patch to the skin. The drugs, sometimes mixed with a chemical that enhances penetration of the skin, pass through the skin to the bloodstream without injection. The transdermal route allows drugs to be delivered slowly and continuously over many hours or days, or even longer. The healthcare market researcher's report, Transdermal and Transmucosal Drug Delivery Markets, analyzes the current and potential market for transdermal drug delivery.  

"New applications continue to emerge for transdermal drug delivery including migraine, HIV, osteoporosis, stroke and restless leg syndrome treatments," said Bruce Carlson, Publisher of Kalorama Information.

Transdermal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Some therapeutic areas stand out, including sex hormones and pain management, due to the successful combination of the individual drug molecules and available product technologies. The potential benefits that may be achieved using transdermal delivery include continuous, controlled release and absorption of medication into the body, improvement of patient compliance by offering convenient dosing regimens such as once or twice weekly dosing and the ability to quickly discontinue treatment by removal of the patch system.

To date, there are numerous transdermal products that have gained significant commercial success and provided unique benefits for patients. In addition to those mentioned previously, smoking cessation, hypertension, pain management and motion sickness are other areas with important transdermal products available. Continued research is necessary to fully appreciate the benefits of transdermal treatments. Certainly challenges remain for the development of transdermal drug delivery systems, but continued research will likely break down the barriers that limit the types of drug molecules that may be delivered through the skin.

The transdermal drug delivery market consists of many companies, including large and small pharmaceutical companies as well as large and small drug delivery companies. The competition among participants is intensifying to provide the best possible vehicle for administration of pharmaceutical products.

Transdermal and Transmucosal Drug Delivery Markets provides the following market information: the worldwide market for transdermal/transmucosal drug delivery technology and pharmaceuticals, 2013-2020; the worldwide market for pharmaceuticals utilizing transdermal/transmucosal drug delivery systems by type, 2013–2020; the worldwide market for pharmaceuticals utilizing transdermal/transmucosal drug delivery technologies, market share by type, 2013-2020; transdermal/transmucosal drug delivery by indication by percent, 2015 (smoking cessation, pain management, hormone, cardio, others); the transdermal/transmucosal drug delivery market by region, 2013-2020 (United States, Europe, Japan, rest of world, global market); the worldwide market for transdermal/transmucosal drug delivery systems, distribution of revenue by pharmaceutical  and drug delivery component, 2013-2020; and leading suppliers of transdermal/transmucosal drug delivery technology.

Transdermal and Transmucosal Drug Delivery Markets can be found at Kalorama Information:  
http://www.kaloramainformation.com/redirect.asp?progid=88246&productid=9495411.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.  

Contact:
Bruce Carlson
(212) 807-2622
[email protected] 
www.KaloramaInformation.com

Logo - http://photos.prnewswire.com/prnh/20150831/262422LOGO

SOURCE Kalorama Information